Likewise, the identical SH3 motif of PACSIN2 binds to the proline‐rich domains of SH3BP1, and SH3BP1 overexpression decreases the susceptibility of CML to nilotinib similar to the function of Cobll1. The gene discussed is PACSIN2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.